Hematopoietic Stem Cell Transplantation in a Very High Risk Group of Patients with the Support of Granulocyte Transfusion

被引:0
|
作者
İdil Yenicesu
Gülsan Sucak
Günter Dilsiz
Şahika Zeynep Akı
Zeynep Arzu Yeğin
机构
[1] Gazi University,Faculty of Medicine, Pediatric Hematology and Blood Bank
[2] Gazi University,Faculty of Medicine, Adult Hematology and Stem Cell Transplantation Unit
[3] Kara Elmas University,Faculty of Medicine, Family Medicine Department
来源
Indian Journal of Hematology and Blood Transfusion | 2011年 / 27卷
关键词
Stem cell transplantation; Granulocyte transfusion; Fungal infection; Anti-fungal treatment;
D O I
暂无
中图分类号
学科分类号
摘要
High risk patients with active fungal infection who had undergone hematopoietic stem cell transplantation (HSCT) with the support of granulocyte transfusions (GTX) as an adjunct to antifungal agents are reviewed retrospectively. Patients requiring immediate allogeneic HSCT for their primary hematological disorders (two severe aplastic anemia, one T cell acute lymphoblastic leukemia (ALL) in second complete remission, one acute myeloid leukemia (AML)-in first complete remission, one T-ALL in refractory relapse) but were denied by other transplant programs due to active invasive fungal infections had undergone HSCT with the support of GTX at the stem cell transplantation unit of Gazi University. Five patients who had undergone six transplants were included in the study and received a total of 38 (3–13) granulocyte transfusions during these six transplants. The median granulocyte concentration was 3.4 × 1011 per apheresis bag. Full clinical and radiological recovery was achieved in three of the five high risk patients with active invasive fungal infection with the combination of antifungal agents and GTX. Even a very high risk patient with aplastic anemia who had undergone two consecutive transplants due to secondary graft failure was also cured of his primary disease despite the presence of multiple pulmonary fungus balls. Three of the five patients with very high risk features due to the underlying hematological disease and the associated active fungal infection were rescued with allogeneic HSCT performed with the support of GTX combined with antifungal agents. Despite the limitations of this report due to its retrospective nature, it suggests that GTX might be an alternative in patients with active fungal infections who otherwise are denied by the transplant programs. However, prospective randomized studies are required to draw a solid conclusion regarding the role of GTX in HSCT recipients in desperate situations such as active fungal infections.
引用
收藏
页码:146 / 151
页数:5
相关论文
共 50 条
  • [31] Outcome of hematopoietic stem cell transplantation of children with very high risk acute lymphoblastic leukemia in first complete remission
    Schechter, Tal
    Ishaqi, Kashif M.
    Rojas, Marta
    Irina, Zaidman
    Doyle, John J.
    Gassas, Adam
    PEDIATRIC TRANSPLANTATION, 2010, 14 (03) : 377 - 382
  • [32] Intrabone Cord Blood Hematopoietic Stem Cell Transplantation in a Subset of Very High-risk Pediatric Patients A Safety and Feasibility Pilot Study
    Saglio, Francesco
    Berger, Massimo
    Vassallo, Elena
    Nesi, Francesca
    Gunetti, Monica
    Fazio, Luigina
    Rustichelli, Deborah
    Ferrero, Ivana
    Fagioli, Franca
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2012, 34 (05) : 359 - 363
  • [33] Cytomegalovirus DNAemia and risk of mortality in allogeneic hematopoietic stem cell transplantation: Analysis from the Spanish Hematopoietic Transplantation and Cell Therapy Group
    Solano, Carlos
    Vazquez, Lourdes
    Gimenez, Estela
    de la Camara, Rafael
    Albert, Eliseo
    Rovira, Montserrat
    Espigado, Ildefonso
    Calvo, Carmen M.
    Lopez-Jimenez, Javier
    Suarez-Lledo, Maria
    Chinea, Anabella
    Esquirol, Albert
    Perez, Ariadna
    Bermudez, Aranzazu
    Saldana, Raquel
    Heras, Inmaculada
    Gonzalez-Huerta, Ana J.
    Torrado, Tamara
    Bautista, Guiomar
    Batlle, Montserrat
    Jimenez, Santiago
    Vallejo, Carlos
    Barba, Pere
    Cuesta, Maria a.
    Pinana, Jose L.
    Navarro, David
    AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 (01) : 258 - 271
  • [34] Hematopoietic Stem Cell Transplantation With Total Body Irradiation Conditioning in Childhood Acute Lymphoblastic Leukemia Patients With Relapsed or High Risk Group
    Kim, G.
    Lee, J. H.
    Jung, M. J.
    Kim, J. Y.
    Chung, N. G.
    Kim, H. K.
    Cho, B.
    Jung, M. H.
    Chung, S. M.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S289 - S289
  • [35] Defibrotide in hematopoietic stem cell transplantation: A multicenter survey study of the Spanish Hematopoietic Stem Cell Transplantation Group (GETH)
    Gonzalez Vicent, Marta
    Diaz de Heredia, Cristina
    Gonzalez de Pablo, Jesus
    Molina, Blanca
    Regueiro, Alexandra
    Perez Martinez, Antonio
    Palomo, Pilar
    Lopez Corral, Lucia
    Garcia, Estefania
    Fernandez, Jose Maria
    Perez, Ariadna
    Jimenez, Maria Jose
    Guerreiro, Manuel
    Vallejo, Carlos
    Gallardo, Ana Isabel
    Lopez, Oriana
    Benito, Ana
    Marsal, Julia
    Duarte, Monica
    Bento, Leyre
    Badell, Isabel
    Pedraza, Alexandra
    Jimenez Ubieto, Ana
    Gonzalez, Pedro
    Gomez Centurion, Ignacio
    Costilla, Lissette
    Belendez, Cristina
    Esquirol, Albert
    Espigado, Ildefonso
    Lavilla, Esperanza
    Diaz, Miguel Angel
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2021, 106 (06) : 842 - 850
  • [36] Impact of Granulocyte Transfusion in Patients Submitted Allogeneic Hematopoietic Progenitor Cell Transplantation - a Single Center Experience in Brazil
    Moreira Funke, Vaneuza Araujo
    Melo, Andresa
    Kloppel, Diogo
    Bitencourt, Marco
    Nabhan, Samir
    Setubal, Daniela C.
    Sola, Caroline
    Oliveira, Michel Michels
    Farias, Joao
    Baldanzi, Giorgio
    Cunha, Clovis Arns
    Bonfim, Carmem
    Pasquini, Ricardo
    Malvezzi, Mariester
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (02) : S222 - S222
  • [37] Methodological and clinical aspects of alloimmunization after granulocyte transfusion in patients undergoing allogeneic stem cell transplantation
    Flaxa, J.
    Rosner, A.
    Hoelig, K.
    Bornhaeuser, M.
    Wassmuth, R.
    TISSUE ANTIGENS, 2015, 85 (02): : 93 - 103
  • [38] Granulocyte transfusion in paediatric haemato-oncology and haematopoietic stem cell transplantation
    Ball, Lynne M.
    REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY, 2007, 12 (03) : 159 - 162
  • [39] Autologous hematopoietic stem cell transplantation for Crohns disease: High risk for a high reward
    Lashner, BA
    INFLAMMATORY BOWEL DISEASES, 2005, 11 (08) : 778 - 779
  • [40] Factors influencing platelet transfusion refractoriness in patients undergoing allogeneic hematopoietic stem cell transplantation
    Solves, Pilar
    Sanz, Jaime
    Freiria, Carmen
    Santiago, Marta
    Villalba, Ana
    Gomez, Ins
    Montesinos, Pau
    Montoro, Juan
    Piana, Jose Luis
    Lorenzo, Jose Ignacio
    Puig, Nieves
    Sanz, Guillermo F.
    Sanz, Miguel Angel
    Carpio, Nelly
    ANNALS OF HEMATOLOGY, 2018, 97 (01) : 161 - 167